Chu Yu-Waye
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Chu Yu-Waye. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CTMX | Chief Medical Officer | Sale | 4,025 | $0.60 | $2,415 | Mar 18, 2025 |
| CTMX | Chief Medical Officer | Award / Grant | 56,000 | — | — | Feb 4, 2025 |
| CTMX | Chief Medical Officer | Award / Grant | 26,250 | — | — | Jan 18, 2024 |
| FATE | Chief Medical Officer | Sale | 2,317 | $6.58 | $15,246 | Apr 18, 2023 |
| FATE | Chief Medical Officer | Sale | 7,825 | $5.24 | $41,003 | Jan 10, 2023 |
| FATE | Chief Medical Officer | Sale | 4,062 | $35.37 | $143,673 | Apr 19, 2022 |
| FATE | Chief Medical Officer | Award / Grant | 33,302 | — | — | Jan 25, 2022 |
| FATE | Senior VP Clinical Development | Sale | 418 | $49.10 | $20,524 | Jan 11, 2022 |
| FATE | Senior VP Clinical Development | Sale | 900 | $50.42 | $45,378 | Dec 10, 2021 |
| FATE | Senior VP Clinical Development | Award / Grant | 60,958 | — | — | Nov 19, 2021 |
| FATE | Senior VP Clinical Development | Sale | 1,500 | $84.41 | $126,615 | Apr 16, 2021 |